東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

COVID-19 = search for a vaccine /

Vogel, Patric U. B.

Linked to FindBook

Google Book

Amazon

博客來

COVID-19 = search for a vaccine /

Record Type:	Electronic resources : Monograph/item
Title/Author:	COVID-19/ by Patric U. B. Vogel.
Reminder of title:	search for a vaccine /
Author:	Vogel, Patric U. B.
Published:	Wiesbaden :Springer Fachmedien Wiesbaden : : 2023.,
Description:	ix, 54 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary.
Contained By:	Springer Nature eBook
Subject:	COVID-19 (Disease) - Prevention. -
Online resource:	https://doi.org/10.1007/978-3-658-38931-4
ISBN:	9783658389314

COVID-19 = search for a vaccine /
Vogel, Patric U. B.

COVID-19search for a vaccine /[electronic resource] :by Patric U. B. Vogel. - Wiesbaden :Springer Fachmedien Wiesbaden :2023. - ix, 54 p. :ill., digital ;24 cm. - essentials. - essentials..

Introduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary.

This book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explained. The content An introduction to the principle of vaccine technologies and their strengths and weaknesses The presentation of successes and failures of vaccines An overview of the currently ongoing vaccine projects against COVID-19 The target groups People with an interest in vaccines, viruses or infectious diseases People who want to better understand the current press releases on COVID-19 vaccine development. The author Patric U. B. Vogel is a biologist with many years of experience with various biopharmaceuticals, from live vaccines to DNA vaccines. He was a registered Qualified Person for several years and has regularly released coronavirus vaccines against animal diseases, among other things. Since 2019, he has been an author, trainer and consultant in the pharmaceutical field. This book is a translation of an original German edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.

ISBN: 9783658389314

Standard No.: 10.1007/978-3-658-38931-4doiSubjects--Topical Terms:

3489934
COVID-19 (Disease)
--Prevention.

LC Class. No.: QR189.5.C68

Dewey Class. No.: 614.5924144

COVID-19 = search for a vaccine /
LDR:02927nmm a2200349 a 4500 001 2314114
003 DE-He213
005 20221202114331.0
006 m d
007 cr nn 008maaau
008 230902s2023 gw s 0 eng d
020 $a 9783658389314 $q (electronic bk.)
020 $a 9783658389307 $q (paper)
024 7 $a 10.1007/978-3-658-38931-4 $2 doi
035 $a 978-3-658-38931-4
040 $a GP $c GP $e rda
041 1 $a eng $h ger
050 4 $a QR189.5.C68
072 7 $a TGM $2 bicssc
072 7 $a SCI013000 $2 bisacsh
072 7 $a TGML $2 thema
082 0 4 $a 614.5924144 $2 23
090 $a QR189.5.C68 $b V879 2023
100 1 $a Vogel, Patric U. B. $3 3625300
240 1 0 $a COVID-19. $l English
245 1 0 $a COVID-19 $h [electronic resource] : $b search for a vaccine / $c by Patric U. B. Vogel.
260 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer Spektrum, $c 2023.
300 $a ix, 54 p. : $b ill., digital ; $c 24 cm.
490 1 $a essentials
505 0 $a Introduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary.
520 $a This book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explained. The content An introduction to the principle of vaccine technologies and their strengths and weaknesses The presentation of successes and failures of vaccines An overview of the currently ongoing vaccine projects against COVID-19 The target groups People with an interest in vaccines, viruses or infectious diseases People who want to better understand the current press releases on COVID-19 vaccine development. The author Patric U. B. Vogel is a biologist with many years of experience with various biopharmaceuticals, from live vaccines to DNA vaccines. He was a registered Qualified Person for several years and has regularly released coronavirus vaccines against animal diseases, among other things. Since 2019, he has been an author, trainer and consultant in the pharmaceutical field. This book is a translation of an original German edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com) A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation.
650 0 $a COVID-19 (Disease) $x Prevention. $3 3489934
650 0 $a COVID-19 vaccines. $3 3625301
650 1 4 $a Biomaterials-Vaccines. $3 3601405
650 2 4 $a Pharmacy. $3 636101
650 2 4 $a Medicinal Chemistry. $3 892420
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a essentials. $3 3264003
856 4 0 $u https://doi.org/10.1007/978-3-658-38931-4
950 $a Chemistry and Materials Science (SpringerNature-11644)